JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$2.54B |
| 2 |
Amazon
AMZN
|
+$1.38B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$827M |
| 4 |
Public Service Enterprise Group
PEG
|
+$725M |
| 5 |
Union Pacific
UNP
|
+$721M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.49B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.03B |
| 3 |
McDonald's
MCD
|
+$1.01B |
| 4 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$871M |
| 5 |
Exelon
EXC
|
+$709M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.19% |
| 2 | Technology | 14.28% |
| 3 | Healthcare | 12.84% |
| 4 | Financials | 10.61% |
| 5 | Consumer Discretionary | 7.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
AXDX
3826
DELISTED
Accelerate Diagnostics
AXDX
| $1.03M | ﹤0.01% |
145,747
+885
| +0.6% | +$9.66K |
2017 Q4
20 quarters
|
|
3827
Jakks Pacific
JAKK
$320M
| $1.03M | ﹤0.01% |
58,761
-28,543
| -33% | -$520K |
2021 Q1
7 quarters
|
|
3828
RPC Inc
RES
$1.31B
| $1.03M | ﹤0.01% |
115,675
+10,183
| +10% | +$91.9K |
2015 Q4
28 quarters
|
|
3829
CALL
Avantor
AVTR
$10.4B
| $1.02M | ﹤0.01% |
+48,600
| New | +$1.01M |
2022 Q4
0 quarters
|
|
3830
Nuveen ESG Mid-Cap Value ETF
NUMV
$436M
| $1.02M | ﹤0.01% |
34,456
+15,938
| +86% | +$491K |
2022 Q3
1 quarter
|
|
3831
Global X SuperDividend ETF
SDIV
$1.16B
| $1.02M | ﹤0.01% |
42,655
+8,119
| +24% | +$195K |
2019 Q4
12 quarters
|
|
3832
American Public Education
APEI
$842M
| $1.02M | ﹤0.01% |
83,169
+21,761
| +35% | +$270K |
2016 Q2
26 quarters
|
|
3833
PUT
Cardinal Health
CAH
$54B
| $1.02M | ﹤0.01% |
13,300
+4,400
| +49% | +$334K |
2021 Q3
5 quarters
|
|
3834
Standard Motor Products
SMP
$830M
| $1.02M | ﹤0.01% |
29,289
-8,512
| -23% | -$311K |
2013 Q2
38 quarters
|
|
3835
ZIM Integrated Shipping Services
ZIM
$3.6B
| $1.02M | ﹤0.01% |
59,320
-108,407
| -65% | -$2.41M |
2021 Q1
7 quarters
|
|
3836
Napco Security Technologies
NSSC
$1.25B
| $1.02M | ﹤0.01% |
36,990
+20,792
| +128% | +$561K |
2017 Q4
20 quarters
|
|
|
CS
3837
PUT
DELISTED
Credit Suisse Group
CS
| $1.02M | ﹤0.01% |
+334,600
| New | +$1.3M |
2022 Q4
0 quarters
|
|
|
BIOT
3838
DELISTED
Biotech Acquisition Company Class A Ordinary Shares
BIOT
| $1.02M | ﹤0.01% |
100,660
-99,340
| -50% | -$995K |
2022 Q2
2 quarters
|
|
|
FSRX
3839
DELISTED
FinServ Acquisition Corp. II Class A Common Stock
FSRX
| $1.01M | ﹤0.01% |
100,781
-67
| -0.1% | -$666 |
2022 Q2
2 quarters
|
|
|
ROSS
3840
DELISTED
Ross Acquisition Corp II
ROSS
| $1.01M | ﹤0.01% |
100,000
-700,000
| -88% | -$7.01M |
2021 Q2
6 quarters
|
|
|
EHAB
3841
DELISTED
Enhabit
EHAB
| $1.01M | ﹤0.01% |
76,735
-61,593
| -45% | -$822K |
2022 Q3
1 quarter
|
|
3842
New Fortress Energy
NFE
$29.5M
| $1.01M | ﹤0.01% |
477
| – | – |
2021 Q4
4 quarters
|
|
3843
Atea Pharmaceuticals
AVIR
$416M
| $1.01M | ﹤0.01% |
210,018
+24,974
| +13% | +$126K |
2020 Q4
8 quarters
|
|
3844
J. Jill
JILL
$367M
| $1.01M | ﹤0.01% |
40,703
+40,693
| +406,930% | +$899K |
2017 Q4
20 quarters
|
|
|
TWLV
3845
DELISTED
Twelve Seas Investment Company II Class A Common Stock
TWLV
| $1.01M | ﹤0.01% |
+100,000
| New | +$994K |
2022 Q4
0 quarters
|
|
|
GXII
3846
DELISTED
GX Acquisition Corp. II Class A Common Stock
GXII
| $1M | ﹤0.01% |
+100,000
| New | +$989K |
2022 Q4
0 quarters
|
|
3847
CALL
Aflac
AFL
$56.6B
| $1M | ﹤0.01% |
+13,900
| New | +$931K |
2022 Q4
0 quarters
|
|
3848
Sweetgreen
SG
$1.09B
| $1M | ﹤0.01% |
116,632
-123,668
| -51% | -$1.8M |
2021 Q4
4 quarters
|
|
3849
PUT
Guardant Health
GH
$22.9B
| $998K | ﹤0.01% |
36,700
-3,900
| -10% | -$178K |
2022 Q3
1 quarter
|
|
|
CVII
3850
DELISTED
Churchill Capital Corp VII Class A Common Stock
CVII
| $997K | ﹤0.01% |
100,000
| – | – |
2021 Q3
5 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2022 Portfolio in Review
As of Q4 2022, JP Morgan Chase held 7,423 positions worth $759B, up 8.9% from $696B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q4 2022 filing shows 754 new, 2,939 increased, 2,285 reduced and 593 closed positions. Its largest new stake was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M. The largest sale was Invesco QQQ Trust, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2022 buy was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M.
- JP Morgan Chase added most to Vanguard Tax-Exempt Bond Index Fund in Q4 2022, an estimated $2.54B increase.
- JP Morgan Chase's biggest Q4 2022 reduction was Invesco QQQ Trust, cutting an estimated $1.49B.
- JP Morgan Chase fully exited Duke Realty Corp. in Q4 2022, selling an estimated $424M.
- JP Morgan Chase's ten largest holdings make up 16% of its $759B portfolio in Q4 2022.
- JP Morgan Chase opened 754 new positions and closed 593 in Q4 2022.
- JP Morgan Chase's portfolio value rose 8.9% quarter-over-quarter to $759B.
Based on JP Morgan Chase's 13F filing for Q4 2022, filed 13 Feb 2023.